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different standards for patients on the basis of 
their socioeconomic status. Although this is a 
laudable long-term goal, it means that hospitals 
with a high proportion of Medicaid patients are 
much more likely to suffer a penalty for exces-
sive readmissions than a hospital with a lower 
proportion of Medicaid patients. This is incred-
ibly bad social policy, discouraging hospitals 
from admitting Medicaid patients. Objections to 
it are not merely theoretical — the published 
penalties show the results of this decision. The 
method used also makes it more likely that a 
large hospital will be hit with a penalty than a 
small hospital with the same readmission rate 
after adjustment for case mix. The data shown 
in Figure 1 support these arguments. 
This issue will grow in importance in the 
next 2 years as the maximum allowable penalty 
increases from 1% of payments to 2% then 3%. 
An additional problem with the method is that 
patients cannot use the results to assess the 
probability of having a readmission at hospitals 
of different sizes or with different dispropor-
tionate share percentages.
J. Graham Atkinson, D.Phil.
1449 44th St., NW 
Washington, DC 
jgatkinson@aol.com
Disclosure forms provided by the author are available with the 
full text of this article at NEJM.org
1. Centers for Medicare and Medicaid Services. Hospital inpa-
tient Prospective Payment Systems for acute care hospitals and 
the long term care hospital Prospective Payment System and 
fiscal year 2013 rates: final rule (http://cms.gov/Medicare/
Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/FY-2013-IPPS 
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Figure 1. Percentage of Hospitals Penalized, 
According to Quartile of Bed Size and Disproportionate 
Share Percentage.
Data are from the Centers for Medicare and Medicaid 
Services.2,3 DSH denotes disproportionate share.
Variola Virus in a 300-Year-Old Siberian Mummy
To the Editor: Smallpox, which is caused by the 
variola virus of the Poxviridae family and the or-
thopoxvirus genus, is among the most devastat-
ing human diseases. It may have originated and 
spread from Egypt, the Near East, or the Indus 
Valley 3000 to 4000 years ago, and historical re-
ports indicate epidemics in China as early as the 
first century A.D. and in Europe during the 6th 
century. By the mid-18th century, smallpox was a 
worldwide endemic disease. It was eradicated af-
ter vaccination campaigns began more than 200 
years ago.1
Variola DNA is about 186 kbp, with genes 
distributed across conserved (central) or variable 
(termini) regions. Sequence analysis has revealed 
two main clusters: clade 1 includes variants of 
variola major, and clade 2 includes West Africa 
strains and variola minor (alastrim).2 The oldest 
sequences that have been characterized originate 
from biologic samples obtained from patients 
during the past five to six decades.
In 2004, a French and Russian team identi-
fied several archeological sites in northeastern 
Siberia (in Sakha Republic [Yakutia], Russian 
Federation). Each site consisted of frozen wooden 
graves buried in the permafrost and dating from 
the late 17th to early 18th century.3 One of these 
graves contained five frozen mummies (Fig. 1A; 
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and see the Supplementary Appendix, available 
with the full text of this letter at NEJM.org). This 
discovery was very unusual, since burial of 
bodies individually was the standard practice in 
Yakutia at that time. Analysis of the grave also 
suggested that the corpses were buried shortly 
after death.4
Biologic samples from mummy 2 were ob-
tained for histologic and molecular investiga-
tions. Microscopical examination of pulmonary 
tissue showed iron inclusions suggestive of the 
presence of blood after a possible hemorrhagic 
episode (Fig. S1 in the Supplementary Appen-
dix). On the basis of these observations, the 
hypothesis of a sudden and lethal infection was 
considered, one of which was variola infection.
We confirmed this hypothesis by performing 
successful polymerase-chain-reaction (PCR) ampli-
fication of three short fragments (B7R/hemag-
glutinin, A30L/14-kD protein, and E9L/DNA poly-
merase) of the variola genome (PoxSib strain, 
718 bp of sequence information) (Fig. S2 in the 
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Figure 1. Grave Containing Five Mummies and Phylogenetic Analysis of Virus Detected in Tissue Samples Obtained 
from Mummy 2. 
Panel A shows a funerary wooden chest identified at the “Shamanic Tree I” site in the Churapcha area of Yakutia. 
The funerary chest was 3.14 m long, 1.10 m wide, and 0.78 m high. Mummy 1 was a male child who was approxi-
mately 5 years of age. Mummy 2 was a female adult who was younger than 23 years of age. Mummy 3 was a female 
adult. Mummy 4 was a male adult who was older than 30 years of age, and mummy 5 was a child who was younger 
than 4 years of age. Panel B shows a phylogenetic analysis of concatenated Siberian variola B7R/A30L/E9L partial 
sequences (PoxSib strain). Numbers in the tree are bootstrap values for relatedness obtained after 1000 replications. 
Maximum likelihood was generated with the use of a Hasegawa–Kishino–Yano model, and node supports were calcu-
lated from 1000 bootstrap pseudoreplicates. PoxSib was the strain identified in this study. Other strains have been 
identified in patients in Guinea in 1969 (Guin69), Sierra Leone in 1969 (SierL69), Benin (formerly Dahomey) in 1968 
(BenDH68), Brazil in 1966 (BrazGar66 and Braz66), Syria in 1972 (Syr72), Pakistan in 1969 (Pak69), India in 1964 
(Ind64), South Africa in 1965 (102Natal) (Sarf65), Botswana in 1972 (Bots72), Ethiopia in 1972 (Ethio72), Bangladesh in 
1975 (Bangla75), Sumatra in 1970 (Sum70), China in 1948 (ChinHorn48), Korea in 1947 (Kor47), Japan in 1951 (Jap51), 
Tanzania in 1965 (Tanz65), and Congo in 1970 (Cng70). CMLV M96 denotes camelpox virus M96, CPXV FIN cowpox 
Finland 2000 MAN, CPXV GER cowpox GER91-3, CPXV GRI cowpox GRI-90, HPXV horsepox virus 76, MPXV Z96 
monkeypox Zaire-96, and VACV vaccinia virus Copenhagen–derived clone 1990.
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Supplementary Appendix). To rule out the persis-
tence of intact viral particles, long-distance PCR 
analyses (E9L assay, approximately 2 kb) were 
performed. No positive results were obtained, 
suggesting an extensive fragmentation of the 
viral genome. Phylogenetic analyses confirmed 
that PoxSib was variola-related, clustering to-
gether with 18 representative variola human se-
quences, but distinct from contemporary clades 1 
and 2 (Fig. 1B). Bayesian analysis that included 
PoxSib extended the origin of smallpox viral 
strains as far back as A.D. 120 (geometric mean, 
A.D. 928). Thus, PoxSib could be a direct pro-
genitor of modern viral strains or a member of 
an ancient lineage that did not cause outbreaks 
in the 20th century. It could be linked to the 
epidemic of 1714, which was described in stud-
ies conducted during the 18th century. The dis-
ease may have been imported to Yakutia during 
Russian conquest.5
These data show that mummified bodies fro-
zen in the Siberian permafrost are a reservoir of 
DNA fragments from ancient pathogens. This 
genetic information could provide clues to past 
epidemics.
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